DBV Technologies (DBVT) Stock
DBV Technologies (DBVT) closed at $9.42 on Nov 19, 2026; its Tenet Score is 31 of 100 against 487 Healthcare peers.
Key stats
- Close
- $9.42
- Nov 19, 2026
- Market cap
- $592.3M
- share price × the latest quarter's diluted weighted-average share count (vendor)
- Dividend yield
- 0.00%
- reinvests all
- 52-week range
- 8.63 – 26.18
- low → high
- Tenet Score
- 31/100
- Weak · 487 Healthcare peers
Industry: Drugs · see every company filed here →
DBV Technologies scores 31/100. Weak. Growth is the soft spot versus 487 Healthcare peers.
Tenet Score · vs sector
n=487Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ~ Drawdown Context
- ✕ Reversal Evidence
Pays no dividend. Every dollar of profit is reinvested into the business.
13F flows & insider trades land here.
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products. Its lead product candidate is Viaskin Peanut, an immunotherapy product, which has completed Phase III clinical…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 13, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Ardelyx IncARDX | 47 | $776.7M |
| Kura Oncology IncKURA | 31 | $713.9M |
| Janux Therapeutics IncJANX | 74 | $695.7M |
| Universe Pharmaceuticals INCUPC | 64 | $688.4M |
| Cullinan Therapeutics IncCGEM | 54 | $667.4M |
| Olema Oncology Inc.OLMA | 55 | $662.3M |
| Immix Biopharma IncIMMX | 69 | $657.1M |
| Arbutus Biopharma CorpABUS | 49 | $627.0M |
| Geron Corp.GERN | 56 | $623.0M |
| Wave Life Sciences Inc.WVE | 54 | $617.3M |
Common questions
What sector and industry is DBV Technologies in?
DBV Technologies is in the Healthcare sector and the Drugs industry.
What is DBV Technologies' Tenet Score?
DBV Technologies' Tenet Score is 31 out of 100, ranked against 487 Healthcare peers as of Nov 20, 2026.




